furosemide and candesartan

furosemide has been researched along with candesartan in 14 studies

Research

Studies (14)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's7 (50.00)29.6817
2010's7 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM1
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ1
Ekins, S; Williams, AJ; Xu, JJ1
Artursson, P; Haglund, U; Karlgren, M; Kimoto, E; Lai, Y; Norinder, U; Vildhede, A; Wisniewski, JR1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Bell, PD; Kovács, G; Peti-Peterdi, J; Rosivall, L1
Brown, NJ; Kumar, S; Murphey, LJ; Sawathiparnich, P; Vaughan, DE1
Briggs, JP; Chen, L; Huang, YG; Kim, SM; Mizel, D; Schnermann, J1
Castrop, H; Hansen, PB; Oppermann, M; Schnermann, J1
Briggs, JP; Chen, L; Faulhaber-Walter, R; Huang, Y; Kim, SM; Mizel, D; Oppermann, M; Schnermann, J1
Ecelbarger, CM; Hu, X; Madala Halagappa, VK; Riazi, S; Tiwari, S1
Hosoya, T; Kuriyama, S; Otsuka, Y; Sugano, N; Ueda, H; Yamada, T; Yoshizawa, T1
Hanawa, H; Kobayashi, D; Kuroda, T; Murakami, S; Nakano, M; Narita, I; Oda, M; Wada, Y1
Akpek, M; Kaya, EG; Kaya, MG; Lam, YY; Sarli, B; Topsakal, R1

Reviews

1 review(s) available for furosemide and candesartan

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016

Trials

2 trial(s) available for furosemide and candesartan

ArticleYear
Effect of combined AT1 receptor and aldosterone receptor antagonism on plasminogen activator inhibitor-1.
    The Journal of clinical endocrinology and metabolism, 2003, Volume: 88, Issue:8

    Topics: Adult; Angiotensin Receptor Antagonists; Benzimidazoles; Biphenyl Compounds; Diuretics; Electrolytes; Female; Fibrinolysis; Furosemide; Hemodynamics; Humans; Male; Mineralocorticoid Receptor Antagonists; Plasminogen Activator Inhibitor 1; Potassium Chloride; Receptor, Angiotensin, Type 1; Renin-Angiotensin System; Single-Blind Method; Spironolactone; Tetrazoles

2003
Tenascin-C as predictor of left ventricular remodeling and mortality in patients with dilated cardiomyopathy.
    Journal of investigative medicine : the official publication of the American Federation for Clinical Research, 2013, Volume: 61, Issue:4

    Topics: Aged; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Carbazoles; Cardiomyopathy, Dilated; Carvedilol; Drug Therapy, Combination; Echocardiography; Female; Furosemide; Heart Function Tests; Hong Kong; Humans; Male; Predictive Value of Tests; Prognosis; Propanolamines; Ramipril; Spironolactone; Survival Rate; Tenascin; Tetrazoles; Turkey; Ventricular Remodeling

2013

Other Studies

11 other study(ies) available for furosemide and candesartan

ArticleYear
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
    Journal of medicinal chemistry, 2008, Oct-09, Volume: 51, Issue:19

    Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship

2008
Developing structure-activity relationships for the prediction of hepatotoxicity.
    Chemical research in toxicology, 2010, Jul-19, Volume: 23, Issue:7

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes

2010
A predictive ligand-based Bayesian model for human drug-induced liver injury.
    Drug metabolism and disposition: the biological fate of chemicals, 2010, Volume: 38, Issue:12

    Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands

2010
Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions.
    Journal of medicinal chemistry, 2012, May-24, Volume: 55, Issue:10

    Topics: Atorvastatin; Biological Transport; Drug Interactions; Estradiol; Estrone; HEK293 Cells; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Least-Squares Analysis; Liver; Liver-Specific Organic Anion Transporter 1; Models, Molecular; Multivariate Analysis; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Protein Isoforms; Pyrroles; Solute Carrier Organic Anion Transporter Family Member 1B3; Structure-Activity Relationship; Transfection

2012
Angiotensin II directly stimulates macula densa Na-2Cl-K cotransport via apical AT(1) receptors.
    American journal of physiology. Renal physiology, 2002, Volume: 282, Issue:2

    Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Benzimidazoles; Biological Transport; Biphenyl Compounds; Cytosol; Diuretics; Furosemide; Imidazoles; Kidney Glomerulus; Microscopy, Fluorescence; Pyridines; Rabbits; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Sodium; Sodium Chloride; Sodium-Potassium-Chloride Symporters; Tetrazoles; Vasoconstrictor Agents

2002
Low plasma renin and reduced renin secretory responses to acute stimuli in conscious COX-2-deficient mice.
    American journal of physiology. Renal physiology, 2007, Volume: 292, Issue:1

    Topics: Adrenergic beta-Agonists; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Cells, Cultured; Cyclooxygenase 2; Diet, Sodium-Restricted; Diuretics; Enalapril; Furosemide; Isoproterenol; Juxtaglomerular Apparatus; Mice; Mice, Inbred C57BL; Mice, Knockout; Renin; Reverse Transcriptase Polymerase Chain Reaction; RNA; Telemetry; Tetrazoles

2007
Vasodilatation of afferent arterioles and paradoxical increase of renal vascular resistance by furosemide in mice.
    American journal of physiology. Renal physiology, 2007, Volume: 293, Issue:1

    Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Arterioles; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Cyclooxygenase Inhibitors; Diuretics; Dose-Response Relationship, Drug; Furosemide; Indomethacin; Kidney Tubules; Male; Mice; Mice, Inbred C57BL; Prostaglandins; Renal Circulation; Sodium Potassium Chloride Symporter Inhibitors; Sodium-Potassium-Chloride Symporters; Solute Carrier Family 12, Member 2; Tetrazoles; Urodynamics; Vascular Resistance; Vasodilation

2007
Regulation of renin secretion and expression in mice deficient in beta1- and beta2-adrenergic receptors.
    Hypertension (Dallas, Tex. : 1979), 2007, Volume: 50, Issue:1

    Topics: Aldosterone; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Benzimidazoles; Biphenyl Compounds; Captopril; Dose-Response Relationship, Drug; Furosemide; Mice; Mice, Knockout; Osmolar Concentration; Receptors, Adrenergic, beta-1; Receptors, Adrenergic, beta-2; Renin; RNA, Messenger; Sodium Chloride, Dietary; Tetrahydroisoquinolines; Tetrazoles

2007
Chronic candesartan alters expression and activity of NKCC2, NCC, and ENaC in the obese Zucker rat.
    American journal of physiology. Renal physiology, 2008, Volume: 294, Issue:5

    Topics: Amiloride; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Blotting, Western; Diuretics; Epithelial Sodium Channels; Furosemide; Hypertrophy; Kidney Tubules, Proximal; Male; Obesity; Rats; Rats, Zucker; Receptor, Angiotensin, Type 1; Receptors, Drug; Renin; Sodium-Hydrogen Exchanger 3; Sodium-Hydrogen Exchangers; Sodium-Phosphate Cotransporter Proteins, Type IIb; Sodium-Potassium-Chloride Symporters; Solute Carrier Family 12, Member 1; Solute Carrier Family 12, Member 3; Symporters; Tetrazoles

2008
Augmented antihypertensive effect of a fixed combination formula of candesartan and hydrochlorothiazide combined with furosemide in a patient on peritoneal dialysis.
    Clinical and experimental nephrology, 2011, Volume: 15, Issue:1

    Topics: Adult; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Diabetic Nephropathies; Diuretics; Drug Therapy, Combination; Female; Furosemide; Humans; Hydrochlorothiazide; Hypertension; Peritoneal Dialysis; Tetrazoles

2011
Cardiac AA amyloidosis in a patient with rheumatoid arthritis and systemic sclerosis: the therapeutic potential of biological reagents.
    Scandinavian journal of rheumatology, 2011, Volume: 40, Issue:5

    Topics: Aged; Amyloidosis; Antibodies, Antinuclear; Antirheumatic Agents; Arthritis, Rheumatoid; Benzimidazoles; Biphenyl Compounds; Carbazoles; Carvedilol; Drug Therapy, Combination; Dyspnea; Etanercept; Female; Furosemide; Glucocorticoids; Hand; Heart Failure; Humans; Immunoglobulin G; Lung Diseases, Interstitial; Natriuretic Peptide, Brain; Propanolamines; Radiography; Receptors, Tumor Necrosis Factor; Rheumatoid Factor; Ribonucleosides; Scleroderma, Systemic; Spironolactone; Sulfasalazine; Tetrazoles; Treatment Outcome

2011